Static compression regulates OPG expression in periodontal ligament cells via the CAMK II pathway

J Appl Oral Sci. 2015 Nov-Dec;23(6):549-54. doi: 10.1590/1678-775720150156.

Abstract

Objective: This study aimed to investigate the potential role of CAMK II pathway in the compression-regulated OPG expression in periodontal ligament cells (PDLCs). MATERIAL AND METHOds: The PDL tissue model was developed by 3-D culturing human PDLCs in a thin sheet of poly lactic-co-glycolic acid (PLGA) scaffolds, which was subjected to static compression of 25 g/cm2 for 3, 6 and 12 h, with or without treatment of KN-93. After that, the expression of OPG, RANKL and NFATC2 was investigated through real-time PCR and western blot analysis.

Results: After static compression, the NFATC2 and RANKL expression was significantly up-regulated, while partially suppressed by KN-93 for 6 and 12 h respectively. The OPG expression was significantly down-regulated by compression in 3 h, started to elevate in 6 h, and significantly up-regulated in 12 h. The up-regulation after 12 h was significantly suppressed by KN-93.

Conclusions: Long-term static compression increases OPG expression in PDLCs, at least partially, via the CAMK II pathway.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Benzylamines / pharmacokinetics
  • Blotting, Western
  • Bone Resorption / metabolism
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2 / metabolism*
  • Cells, Cultured
  • Down-Regulation
  • Humans
  • NFATC Transcription Factors / metabolism
  • Osteogenesis / physiology*
  • Osteoprotegerin / metabolism*
  • Periodontal Ligament / cytology*
  • Pressure
  • Protein Kinase Inhibitors / pharmacokinetics
  • RANK Ligand / analysis
  • RANK Ligand / metabolism
  • Random Allocation
  • Real-Time Polymerase Chain Reaction
  • Sulfonamides / pharmacokinetics
  • Time Factors
  • Up-Regulation

Substances

  • Benzylamines
  • NFATC Transcription Factors
  • NFATC2 protein, human
  • Osteoprotegerin
  • Protein Kinase Inhibitors
  • RANK Ligand
  • Sulfonamides
  • TNFSF11 protein, human
  • KN 93
  • Calcium-Calmodulin-Dependent Protein Kinase Type 2